Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
ucsf
3
×
autoimmune
crispr
geneediting
genetherapy
medicine
tcell
tomorrow
acetylon pharmaceuticals
ambys medicines
biotech
boston blog main
boston top stories
cas9
cell therapy
constellation pharmaceuticals
deals
dna
gene therapy
genentech
holger willenbring
immunity
ipo
jeffrey tong
juan carlos izpisua belmonte
keith dionne
life sciences
liver disease
markus grompe
martin burke
national blog main
national top stories
new york blog main
new york top stories
oregon stem cell center
proteon therapeutics
salk institute for biological studies
san diego blog main
san diego top stories
san francisco
What
diseases
3
×
autoimmune
cells
promising
reprogram
scientists
specific
target
technique
therapies
viral
aiming
ambys
big
biotech
control
deadly
deal
debuted
formed
future
launch
liver
make
medicines
new
startup
takeda
today
treatments
unusual
variety
Language
Current search:
ucsf
×
diseases
×
@xconomy.com
5 years ago
With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future?
@engadget.com
5 years ago
Scientists reprogram T Cells to target autoimmune diseases
@engadget.com
5 years ago
Scientists reprogram T Cells to target autoimmune diseases
